$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000109355718000230 Filed on November 06, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q4
Revenue	$338.0M	$266.7M	$221.0M
YoY Change	52.94%	44.47%	29.09%
Cost Of Revenue	$115.2M	$98.10M	$67.50M
YoY Change	70.67%	70.31%	23.85%
Gross Profit	$222.8M	$168.6M	$153.5M
YoY Change	45.15%	32.76%	31.53%
Gross Profit Margin	65.92%	63.22%	69.46%
Selling, General & Admin	$112.1M	$104.6M	$92.80M
YoY Change	20.8%	24.23%	17.32%
% of Gross Profit	50.31%	62.04%	60.46%
Research & Development	$275.3M	$50.10M	$48.70M
YoY Change	465.3%	15.7%	11.44%
% of Gross Profit	123.56%	29.72%	31.73%
Depreciation & Amortization	$8.600M	$7.800M	$16.10M
YoY Change	-46.58%	81.4%	347.22%
% of Gross Profit	3.86%	4.63%	10.49%
Operating Expenses	$387.4M	$154.7M	$141.5M
YoY Change	173.78%	21.33%	15.23%
Operating Profit	-$164.6M	$13.90M	$12.00M
YoY Change	-1471.67%	-2880.0%	-296.72%
Interest Expense	-$16.90M	$4.900M	-$3.300M
YoY Change	412.12%	8.89%	1550.0%
% of Operating Profit		35.25%	-27.5%
Other Income/Expense, Net	$4.600M	$900.0K	-$100.0K
YoY Change	-4700.0%	-30.77%	-85.71%
Pretax Income	-$176.9M	$44.80M	$12.40M
YoY Change	-1526.61%	-1892.0%	-277.14%
Income Tax	$3.200M	-$1.800M	$1.600M
% Of Pretax Income		-4.02%	12.9%
Net Earnings	-$179.7M	$46.60M	-$9.400M
YoY Change	1811.7%	-2430.0%	27.03%
Net Earnings / Revenue	-53.17%	17.47%	-4.25%
Basic Earnings Per Share	-$2.03	$0.53	-$0.11
Diluted Earnings Per Share	-$2.03	$0.52	-$0.11
COMMON SHARES
Basic Shares Outstanding	88.84M shares	88.50M shares	86.90M shares
Diluted Shares Outstanding		90.30M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.230B	$625.9M	$548.6M
YoY Change	124.15%	19.04%	343.49%
Cash & Equivalents	$1.137B	$367.4M	$441.5M
Short-Term Investments	$92.70M	$258.5M	$107.1M
Other Short-Term Assets	$16.50M	$20.40M	$16.60M
YoY Change	-0.6%	53.38%	80.43%
Inventory	$70.70M	$55.20M	$45.20M
Prepaid Expenses
Receivables	$226.7M	$169.8M	$134.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.700B	$914.1M	$744.7M
YoY Change	128.21%	31.92%	165.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.1M	$169.6M	$145.6M
YoY Change	25.76%	24.61%	33.09%
Goodwill	$18.70M	$18.40M	$12.10M
YoY Change	54.55%	53.33%	7.08%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.70M	$12.20M	$1.700M
YoY Change	764.71%	542.11%	-19.05%
Total Long-Term Assets	$216.5M	$200.2M	$159.4M
YoY Change	35.82%	33.47%	29.8%
TOTAL ASSETS
Total Short-Term Assets	$1.700B	$914.1M	$744.7M
Total Long-Term Assets	$216.5M	$200.2M	$159.4M
Total Assets	$1.916B	$1.114B	$904.1M
YoY Change	111.92%	32.2%	124.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$75.50M	$57.70M	$46.70M
YoY Change	61.67%	147.64%	90.61%
Accrued Expenses	$144.0M	$132.7M	$89.00M
YoY Change	61.8%	43.3%	15.58%
Deferred Revenue	$2.900M		$3.200M
YoY Change	-9.38%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$222.4M	$193.9M	$138.9M
YoY Change	60.12%	64.04%	35.64%
LONG-TERM LIABILITIES
Long-Term Debt	$1.018B	$346.1M	$334.3M
YoY Change	204.4%	4.66%
Other Long-Term Liabilities	$20.00M	$19.40M	$18.20M
YoY Change	9.89%	16.17%	9.64%
Total Long-Term Liabilities	$20.00M	$19.40M	$18.20M
YoY Change	9.89%	16.17%	9.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$222.4M	$193.9M	$138.9M
Total Long-Term Liabilities	$20.00M	$19.40M	$18.20M
Total Liabilities	$1.253B	$552.1M	$484.7M
YoY Change	158.45%	20.31%	307.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$798.9M	-$619.2M	-$671.8M
YoY Change	18.92%	-6.52%	8.18%
Common Stock	$1.561B	$1.182B	$1.094B
YoY Change	42.69%	12.69%	20.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$100.0M		$0.00
YoY Change
Treasury Stock Shares	800.0K shares		0.000 shares
Shareholders Equity	$663.3M	$562.2M	$419.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.916B	$1.114B	$904.1M
YoY Change	111.92%	32.2%	124.45%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q4
OPERATING ACTIVITIES
Net Income	-$179.7M	$46.60M	-$9.400M
YoY Change	1811.7%	-2430.0%	27.03%
Depreciation, Depletion And Amortization	$8.600M	$7.800M	$16.10M
YoY Change	-46.58%	81.4%	347.22%
Cash From Operating Activities	$33.70M	$56.80M	$41.20M
YoY Change	-18.2%	56.91%	209.77%
INVESTING ACTIVITIES
Capital Expenditures	-$17.70M	-$23.80M	-$17.60M
YoY Change	0.57%	76.3%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$48.60M	$28.40M	$16.50M
YoY Change	194.55%	-222.94%	5400.0%
Cash From Investing Activities	$30.90M	$4.600M	-$1.100M
YoY Change	-2909.09%	-112.57%	-93.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	701.6M	5.400M	100.0K
YoY Change	701500.0%	25.58%	-80.0%
NET CHANGE
Cash From Operating Activities	33.70M	56.80M	41.20M
Cash From Investing Activities	30.90M	4.600M	-1.100M
Cash From Financing Activities	701.6M	5.400M	100.0K
Net Change In Cash	766.2M	66.80M	40.20M
YoY Change	1805.97%	1612.82%	-1248.57%
FREE CASH FLOW
Cash From Operating Activities	$33.70M	$56.80M	$41.20M
Capital Expenditures	-$17.70M	-$23.80M	-$17.60M
Free Cash Flow	$51.40M	$80.60M	$58.80M
YoY Change	-12.59%	62.17%	90.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	0	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1900000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8600000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88844345	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
	dei	Trading Symbol TradingSymbol	DXCM
CY2017Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	7100000	USD
CY2018Q3	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	18300000	USD
CY2017Q4	dxcm	Debt Instrument Current Value Upon Conversion DebtInstrumentCurrentValueUponConversion	0	USD
CY2018Q3	dxcm	Debt Instrument Current Value Upon Conversion DebtInstrumentCurrentValueUponConversion	207000000	USD
CY2018Q3	dxcm	Effective Income Tax Rate Reconciliation Tax Benefit For Refunds Of Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationTaxBenefitForRefundsOfForeignWithholdingTax	2300000	USD
	dxcm	Effective Income Tax Rate Reconciliation Tax Benefit For Refunds Of Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationTaxBenefitForRefundsOfForeignWithholdingTax	2300000	USD
CY2017Q3	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2018Q3	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2017Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	6700000	USD
CY2018Q3	dxcm	Financing Lease Obligation FinancingLeaseObligation	7300000	USD
CY2017Q4	dxcm	Pharmacy Rebates PharmacyRebates	13900000	USD
CY2018Q3	dxcm	Pharmacy Rebates PharmacyRebates	34700000	USD
	dxcm	Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm	P1Y
	dxcm	Revenue Recognition Sales Returns Coverage Period RevenueRecognitionSalesReturnsCoveragePeriod	P30D
CY2017Q3	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	5400000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	13900000	USD
CY2018Q3	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	3900000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	11800000	USD
CY2017Q4	dxcm	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	105700000	USD
CY2017Q4	dxcm	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense	0	USD
CY2018Q3	dxcm	Working Capital WorkingCapital	720200000	USD
CY2017Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	87200000	USD
CY2018Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	135400000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	46700000	USD
CY2018Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	57700000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134300000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	169800000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54800000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	72300000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2600000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-300000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1093700000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1181600000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5700000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11300000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4300000	shares
CY2017Q4	us-gaap	Assets Assets	904100000	USD
CY2018Q3	us-gaap	Assets Assets	1114300000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	744700000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	914100000	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	258600000	USD
CY2017Q3	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	0	USD
	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	0	USD
CY2018Q3	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	20800000	USD
	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	40800000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	107100000	USD
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	301300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	40800000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000	USD
CY2018Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	107300000	USD
CY2018Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	260600000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	258500000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	107100000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	258500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	441500000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367400000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	668700000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94500000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	402100000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441500000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367700000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	307600000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-73800000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	344600000	USD
CY2018Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	215400000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87300000.0	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89100000.0	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87000000.0	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88800000.0	shares
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2018Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42000000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	54900000	USD
CY2017Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	381300000	USD
CY2018Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	618800000	USD
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	327600000	USD
CY2018Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	338800000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	57600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	158900000	USD
CY2018Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	98100000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	252500000	USD
CY2017Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000000	USD
CY2018Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000000.0	USD
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	64400000	USD
CY2018Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	54400000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8700000	USD
CY2018Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	7500000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3200000	USD
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3500000	USD
CY2018Q3	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	5000000	USD
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20500000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1100000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1400000	USD
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.29
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.04
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.04
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48500000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	55000000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	150100000	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	44100000	USD
CY2017Q3	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2018Q3	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2017Q4	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	41200000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	0	USD
CY2018Q3	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	-14100000	USD
	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	-44200000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	0	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	0	USD
CY2018Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	34900000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	85000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	12100000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	18400000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	127000000	USD
	us-gaap	Gross Profit GrossProfit	338600000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	168600000	USD
	us-gaap	Gross Profit GrossProfit	441100000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57200000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	50400000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16400000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2200000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12500000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50200000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8200000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36200000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1400000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	300000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1600000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	6200000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2200000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10000000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1900000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	600000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3700000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3400000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	4500000	USD
	us-gaap	Interest Expense InterestExpense	8100000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	4900000	USD
	us-gaap	Interest Expense InterestExpense	14500000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17000000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22800000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	45200000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	55200000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20000000	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21800000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8200000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10600000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1200000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2500000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6200000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8300000	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2900000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	484700000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	552100000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	904100000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1114300000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	138900000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	193900000	USD
CY2018Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	195600000	USD
CY2018Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q3	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2018Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8800000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-143300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-170700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	89500000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40800000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	46600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	52600000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6500000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3000000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	127500000	USD
	us-gaap	Operating Expenses OperatingExpenses	393100000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	154700000	USD
	us-gaap	Operating Expenses OperatingExpenses	462800000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54500000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13900000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21700000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	59800000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4200000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	15100000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	14700000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	13800000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9400000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2600000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10700000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18300000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1700000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12200000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-600000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1200000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	900000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2200000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18200000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19400000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3200000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5000000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1300000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3500000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4600000	USD
CY2017Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2800000	USD
CY2018Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4600000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1800000	USD
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-3600000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	141900000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	340000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11300000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48400000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49400000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16600000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20400000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	389000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10600000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	47000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	231000000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5000000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	15000000	USD
CY2018Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5000000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	14200000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	200400000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	241900000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145600000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169600000	USD
CY2018Q3	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	126000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	136700000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50100000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	142100000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	300000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-671800000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-619200000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	266700000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	693600000	USD
	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	We generally do not have any contracts or performance obligations with a term of more than one year.
CY2017Q3	us-gaap	Revenues Revenues	184600000	USD
	us-gaap	Revenues Revenues	497500000	USD
CY2018Q3	us-gaap	Revenues Revenues	266700000	USD
	us-gaap	Revenues Revenues	693600000	USD
CY2018Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	2300000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	256400000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104600000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	320700000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	25400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81300000	USD
CY2018Q3	us-gaap	Share Based Compensation ShareBasedCompensation	27100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	77300000	USD
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9800000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8300000	USD
CY2017Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8700000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8800000	USD
CY2018Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7500000	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6400000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419400000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	40800000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8000000	USD
CY2018Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6800000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	562200000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86100000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89300000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86100000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88000000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring (“CGM”)</font><font style="font-family:inherit;font-size:10pt;"> systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">U.S. GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates include excess or obsolete inventories, valuation of inventory, warranty accruals, convertible debt, employee bonus, clinical trial expenses, allowance for bad debt, refunds, rebates, including pharmacy rebates and self-funded insurance liabilities. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-18-000230-index-headers.html	Edgar Link	pending
0001093557-18-000230-index.html	Edgar Link	pending
0001093557-18-000230.txt	Edgar Link	pending
0001093557-18-000230-xbrl.zip	Edgar Link	pending
dxcm-20180930.xml	Edgar Link	completed
dxcm-20180930.xsd	Edgar Link	pending
dxcm-20180930_cal.xml	Edgar Link	unprocessable
dxcm-20180930_def.xml	Edgar Link	unprocessable
dxcm-20180930_lab.xml	Edgar Link	unprocessable
dxcm-20180930_pre.xml	Edgar Link	unprocessable
dxcm-93018x10q.htm	Edgar Link	pending
dxcm9302018exhibit3101.htm	Edgar Link	pending
dxcm9302018exhibit3102.htm	Edgar Link	pending
dxcm9302018exhibit3201.htm	Edgar Link	pending
dxcm9302018exhibit3202.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2018 Q4 Form 10-Q Financial Statement

#000109355718000230 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2018 Q4 Form 10-Q Financial Statement

#000109355718000230 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm